-
Affinia Therapeutics Announces FDA Acceptance of IND Application to Advance AFTX-201 to a Phase 1/2 Trial for the Treatment of BAG3-Associated Dilated Cardiomyopathy (DCM)
04 Feb 2026 16:56 GMT
… has accepted its Investigational New Drug (IND) application for AFTX- … © clinical trial is a multicenter, open-label Phase 1/2 clinical trial designed … KEYWORD: RESEARCH FDA GENETICS CLINICAL TRIALS CARDIOLOGY BIOTECHNOLOGY HEALTH PHARMACEUTICAL SCIENCE …
-
Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026
04 Feb 2026 13:00 GMT
… featuring data from the Phase 1 trial of intratumoral UNO … U.S. Food and Drug Administration (FDA). The ventilator … pre-clinical studies and clinical trials; the potential that regulatory … pre-clinical studies and clinical trials of our product candidates; …
-
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of Lu-PSMA-I&T for Prostate Cancer in Japan
04 Feb 2026 06:30 GMT
… Curium’s ongoing global clinical trials under the strategic … National Cancer Center Japan Clinical trial progress Phase 3 ECLIPSE … The first in human Phase 1/2 SOLAR trial … investigational peptide therapeutics, peptide drug conjugates (PDC) and …
-
<![CDATA[Expert: Early Phase 1 Data Shows KTX-1001 Targeting NSD2 Offers Promise for Relapsed/Refractory Multiple Myeloma]]>
03 Feb 2026 18:36 GMT
… discussed updated results from a Phase 1 clinical trial of KTX-1001 (Gintamatostat; … across diverse populations.
The Phase 1 study enrolled heavily pretreated, … , including proteasome inhibitors, immunomodulatory drugs, and anti-CD38 monoclonal antibodies …
-
MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study
03 Feb 2026 15:43 GMT
… cohort of its Phase 1 multiple ascending dose (MAD) clinical trial evaluating Ketamir-2 … randomized, double-blind, placebo-controlled Phase 1 study is designed to evaluate … .S. Food and Drug Administration (FDA) following completion of Phase 1. Subject to …
-
Therapeutic Approaches for Cutaneous Lupus Erythematosus: a Changing Landscape of Clinical Trials
03 Feb 2026 15:28 GMT
… and Clinical Trial Endpoints
In clinical trials that evaluate drugs for … primary endpoint for clinical trials, drug development is … CLE clinical trials. Timeline of important CLE clinical trials including … , et al. Phase 1 study in healthy participants …
-
Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program
03 Feb 2026 13:30 GMT
… diligence, nonclinical strategy and clinical trial integrity for novel intranasal … experience with market-leading drug programs will meaningfully … . The firm’s Phase 1 and 2 clinical study … and outcomes of our clinical trials of our product candidates …
-
Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026
03 Feb 2026 13:00 GMT
… the investigator sponsored Phase 1 clinical study (NCT03284268 … 01 has Orphan Drug and Rare Pediatric … a potential pivotal clinical trial design in retinoblastoma … clinical trials on time and achieve the desired results and benefits, continuing clinical trial …
-
ConcertAI Launches Accelerated Clinical Trials, Leveraging Agentic AI to Radically Shorten Trial Timelines
03 Feb 2026 08:10 GMT
… SaaS technology company, unveiled Accelerated Clinical Trials (ACT), an enterprise agentic … Study of Drug Development (CSDD) found that 76% of Phase I-IV trials … achieve greater accuracy throughout the clinical trial lifecycle. For development teams, …
-
AI in Drug Discovery Market to Reach US$ 8.10 Billion by 2030 as AI Transforms Pharmaceutical R&D Efficiency | Astute Analytica
03 Feb 2026 21:18 GMT
… and phase 1 clinical trials.
One of the biggest challenges in drug discovery … technologies help streamline drug development processes, improve clinical trial designs, and … Others Technologies
By Application
Drug optimization and repurposing
Preclinical …